268 related articles for article (PubMed ID: 22113471)
1. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis.
Tejasvi T; Stuart PE; Chandran V; Voorhees JJ; Gladman DD; Rahman P; Elder JT; Nair RP
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):593-600. PubMed ID: 22113471
[TBL] [Abstract][Full Text] [Related]
2. TNFAIP3 and IL12B gene polymorphisms associated with psoriasis vulgaris in an Egyptian cohort.
Haase O; Mosaad H; Eldarouti MA; Elramly AZ; Samir N; Abdelhady MM; Samir M; El-Gharib I; Salah S; El-Shennawy FA; Mosaad Y; Elwan N; Salem H; Abdelgaber S; Recke A; Möller S; Zillikens D; Ibrahim S
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1297-301. PubMed ID: 25406098
[TBL] [Abstract][Full Text] [Related]
3. The TNFAIP3 polymorphism rs610604 both associates with the risk of psoriasis vulgaris and affects the clinical severity.
Zhang C; Zhu KJ; Liu H; Quan C; Liu Z; Li SJ; Zhu CY; Li KS; Fan YM
Clin Exp Dermatol; 2015 Jun; 40(4):426-30. PubMed ID: 25496073
[TBL] [Abstract][Full Text] [Related]
4. TNFAIP3 and TNIP1 polymorphisms confer psoriasis risk in South Indian Tamils.
Indhumathi S; Rajappa M; Chandrashekar L; Ananthanarayanan PH; Thappa DM; Negi VS
Br J Biomed Sci; 2015; 72(4):168-73. PubMed ID: 26738398
[TBL] [Abstract][Full Text] [Related]
5. The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis.
Fan Y; Tao JH; Zhang LP; Li LH; Ye DQ
Int J Immunogenet; 2011 Apr; 38(2):151-9. PubMed ID: 21208380
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the TNFAIP3 region in psoriasis reveals a risk haplotype that is distinct from other autoimmune diseases.
Nititham J; Taylor KE; Gupta R; Chen H; Ahn R; Liu J; Seielstad M; Ma A; Bowcock AM; Criswell LA; Stahle M; Liao W
Genes Immun; 2015 Mar; 16(2):120-6. PubMed ID: 25521225
[TBL] [Abstract][Full Text] [Related]
7. TNFAIP3 gene polymorphisms associated with differential susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Korean population.
Kim SK; Choe JY; Bae J; Chae SC; Park DJ; Kwak SG; Lee SS
Rheumatology (Oxford); 2014 Jun; 53(6):1009-13. PubMed ID: 24489017
[TBL] [Abstract][Full Text] [Related]
8. African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity.
Lodolce JP; Kolodziej LE; Rhee L; Kariuki SN; Franek BS; McGreal NM; Logsdon MF; Bartulis SJ; Perera MA; Ellis NA; Adams EJ; Hanauer SB; Jolly M; Niewold TB; Boone DL
J Immunol; 2010 Jun; 184(12):7001-9. PubMed ID: 20483768
[TBL] [Abstract][Full Text] [Related]
9. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
[TBL] [Abstract][Full Text] [Related]
10. Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes.
Boonyasrisawat W; Eberle D; Bacci S; Zhang YY; Nolan D; Gervino EV; Johnstone MT; Trischitta V; Shoelson SE; Doria A
Diabetes; 2007 Feb; 56(2):499-505. PubMed ID: 17259397
[TBL] [Abstract][Full Text] [Related]
11. Association of rs610604 in TNFAIP3 and rs17728338 in TNIP1 gene polymorphisms with psoriasis susceptibility: a meta-analysis of case-control studies.
Gong HB; Gao ST; Pu XM; Kang XJ; Wu XJ
BMC Med Genet; 2020 May; 21(1):103. PubMed ID: 32398022
[TBL] [Abstract][Full Text] [Related]
12. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus.
Musone SL; Taylor KE; Lu TT; Nititham J; Ferreira RC; Ortmann W; Shifrin N; Petri MA; Kamboh MI; Manzi S; Seldin MF; Gregersen PK; Behrens TW; Ma A; Kwok PY; Criswell LA
Nat Genet; 2008 Sep; 40(9):1062-4. PubMed ID: 19165919
[TBL] [Abstract][Full Text] [Related]
13. Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.
Hoffjan S; Okur A; Epplen JT; Wieczorek S; Chan A; Akkad DA
Int J Immunogenet; 2015 Apr; 42(2):106-10. PubMed ID: 25684197
[TBL] [Abstract][Full Text] [Related]
14. Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis.
Murdaca G; Negrini S; Magnani O; Penza E; Pellecchio M; Puppo F
Expert Opin Drug Saf; 2017 Oct; 16(10):1173-1179. PubMed ID: 28750567
[TBL] [Abstract][Full Text] [Related]
15. Functional effect of polymorphisms in the promoter of TNFAIP3 (A20) in acute pancreatitis in the Han Chinese population.
Liu Y; Dan G; Wu L; Chen G; Wu A; Zeng P; Xu W
PLoS One; 2014; 9(7):e103104. PubMed ID: 25050625
[TBL] [Abstract][Full Text] [Related]
16. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy.
Iyer S; Yamauchi P; Lowe NJ
Br J Dermatol; 2002 Jan; 146(1):118-21. PubMed ID: 11841377
[TBL] [Abstract][Full Text] [Related]
17. Association of TNFAIP3 polymorphism with susceptibility to systemic lupus erythematosus in a Japanese population.
Kawasaki A; Ito I; Ito S; Hayashi T; Goto D; Matsumoto I; Takasaki Y; Hashimoto H; Sumida T; Tsuchiya N
J Biomed Biotechnol; 2010; 2010():207578. PubMed ID: 20617138
[TBL] [Abstract][Full Text] [Related]
18. Investigating the genetic association of HCP5, SPATA2, TNIP1, TNFAIP3 and COG6 with psoriasis in Chinese population.
Li XL; Yu H; Wu GS
Int J Immunogenet; 2014 Dec; 41(6):503-7. PubMed ID: 25264125
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
[TBL] [Abstract][Full Text] [Related]
20. TNFAIP3 rs2230926 polymorphisms in rheumatoid arthritis of southern Chinese Han population: a case-control study.
Hao G; Li Y; Liu J; Wo M
Int J Clin Exp Pathol; 2014; 7(12):8958-61. PubMed ID: 25674272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
